VPS33B and acute myeloid leukemia: Consistently, silencing exosome-assembly protein VPS33B in both human AML cell lines (HL-60, THP-1, and U937) and AML patient samples led to a significant delay in cell proliferation and increased apoptosis in both CD34+-enriched LICs and bulk leukaemic blasts [53].